Table 2.
Relationship between survival and prognostic factors in epithelial ovarian cancer
| Variable | Overall survival (Months) | Recurrence-free survival (Months) | |
|---|---|---|---|
| Histological type | Serous Adenocarcinoma | 72.81 | 32.92 |
| Mucinous Adenocarcinoma | 58.1 | 47.79 | |
| Endometroid Adenocarcinoma | 7.6 | 6 | |
| Clear Cell Adenocarcinoma | 43.46 | 43.17 | |
| Poorly Differentiated Adenocarcinoma | 13 | 8 | |
| Metastatic carcinoma | 52.65 | 38.78 | |
| p-value | 0.000 | 0.0795 | |
| Surgical procedures | Cytoreductive Surgery | 48.83 | 23.89 |
| Removal of both ovaries and the uterus | 72.2 | 43.50 | |
| Complete tumor resection | 43.50 | ||
| Removal of fallopian tubes and ovaries | 84.71 | 37.21 | |
| p-value | 0.2339 | 0.1803 | |
| Chemotherapy | Received | 37.95 | 72.31 |
| Not Given | 37.66 | 77.28 | |
| p-value | 0.4012 | 0.11 | |
| Stage of disease | Stage I | 84.18 | |
| Stage II | 67.08 | ||
| Stages III | 48.73 | ||
| Stage IV | 10 | ||
| p-value | 0.0377 | ||
| Age | 18–49 | 60.07 | |
| 50–59 | 83.34 | ||
| 60–89 | 57.14 | ||
| p-value | 0.613 | ||